The first part focuses on OCB as diagnostic biomarker for MS and briefly describes other diagnostic markers such as aquaporin4 (AQP4) and biomarkers that are about to enter clinical routine, such as anti-myelin oligodendrocyte glycoprotein (MOG). The gene discussed is AQP4; the disease is myeloid sarcoma.